Inside Pharma Leadership

About Inside Pharma Leadership

On Inside Pharma Leadership, I sit down with leaders and thinkers across the life sciences to talk about what it takes to lead, perform, and execute in complex environments Each episode features conversations with executives, managers, and thought leaders from across the pharma and broader life sciences ecosystem. We explore what leadership really looks like behind the scenes—how decisions get made, where execution breaks down, and what it takes to build teams that perform in highly regulated, high-stakes environments. This podcast focuses on real-life experiences, including leading through change, managing performance, developing people, and translating strategy into effective day-to-day execution. Whether you work in sales, medical affairs, market access, training, operations, or leadership development, Inside Pharma Leadership offers insights, reflection, and lessons you can apply.

Publisher

Keith Willis

Category

business

Language

en

Explicit

No

First episode

4 Mar 2026

Latest episode

8 Oct 2026

Latest episodes

19 episodes in the feed.

1. 

   8 Oct 2026

   Ep18 - What Happens to Learning When AI Changes Everything with Wanda Shoer

   In this episode of Inside Pharma Leadership, I sit down with Wanda Shoer, Chief Learning Officer at Sanofi, to explore how learning and development is evolving in a rapidly changing pharma environment. We discuss reskilling, AI, learning operating models, human connection, and how organizations can create space for people to think, learn, and innovate. Meet the Guest Wanda Shoer is the Chief Learning Officer at Sanofi. Her career spans HR transformation, R&D strategy, drug development, and learning and development. Her experience across different areas of the pharma business gives her a unique perspective on connecting people, learning, and business needs in a rapidly changing industry. Key Takeaways Learning has to move at the speed of change: Organizations need to invest in reskilling and upskilling as AI and new ways of working reshape the industry. The CLO role is evolving: Learning leaders can help connect fragmented learning efforts, reduce redundancy, and better align learning with business priorities. AI ownership matters less than enablement: The bigger question is whether employees are being equipped to use AI productively and innovatively in their roles. Context is critical when working with AI: The more relevant context people provide, the more useful and personalized AI outputs can become. Human connection still matters: AI can support learning, but relationships, collaboration, and human connection remain important parts of development. AI could create space for deeper thinking: Automating routine work may give people more time to focus on creativity, problem-solving, and innovation, if organizations deliberately protect that time. Learning is becoming more experiential: Wanda shares how her perspective shifted from learning through deep study and certification toward applying frameworks, coaching, and learning what is needed in the moment. Connect with Wanda Shoer: LinkedIn: https://www.linkedin.com/in/castilloshoer/ (https://www.linkedin.com/in/castilloshoer/) Sanofi's Website: https://www.sanofi.com/en (https://www.sanofi.com/en) _______________________________________________________________________ Connect with Keith Willis & Inside Pharma Leadership Instagram: https://www.instagram.com/coachtoachieve/ (https://www.instagram.com/coachtoachieve/) LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

2. 

   28 Sept 2026

   Ep17 - The Microbiome Revolution: From Gut Health to Precision Medicine with Brian Russon

   In this episode of Inside Pharma Leadership, I sit down with Brian Russon, CEO of PhenoBiome, to explore the growing role of the microbiome in health and precision nutrition. We discuss the challenges of separating science from noise, the path toward clinical validation, personalized health solutions, and how AI is helping accelerate research and innovation in healthcare. Brian Russon is the CEO of PhenoBiome, a company focused on microbiome-driven health through precision nutrition. With a background in digital health, health technology, telehealth, and patient navigation, Brian brings experience across healthcare innovation and commercialization. He is focused on advancing science-backed microbiome solutions and building partnerships that can bring those solutions to a broader market. Separating science from the noise: The microbiome market has growing interest, but clinical validation remains critical to moving beyond anecdotal claims. Precision nutrition is evolving: Understanding an individual's microbiome could help create more customized nutrition and health solutions. Prebiotics and probiotics work together: A healthy environment may be just as important as introducing beneficial bacteria. AI is accelerating research: PhenoBiome uses AI to support research, genetic sequencing analysis, reporting, analytics, and education. Healthcare innovation takes time: Brian shares why meaningful healthcare innovation often moves slower than expected, particularly because of regulatory, reimbursement, and clinical considerations. The microbiome could become part of routine care: Brian discusses the potential for microbiome testing to become part of annual wellness visits and preventative care. Connect with Brian Russon and learn more about PhenoBiome: LinkedIn: https://www.linkedin.com/in/brianrusson/ (https://www.linkedin.com/in/brianrusson/) PhenoBiome: phenobiome.com Email: brian@phenobiome.com (mailto:brian@phenobiome.com) --- Connect with Keith Willis & Inside Pharma Leadership Instagram: https://www.instagram.com/coachtoachieve/ (https://www.instagram.com/coachtoachieve/) LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

3. 

   11 Sept 2026

   Ep16 - Authenticity Isn’t Enough: What Makes a Great Leader with Ken Sher

   In this episode of Inside Pharma Leadership, I sit down with Ken Sher to explore what authentic leadership really looks like. We discuss the difference between being authentic and being effective, how leaders build trust, and why helping others succeed is at the heart of meaningful leadership. Meet the Guest Ken Sher is a pharmaceutical industry leader with extensive experience in commercial leadership, team development, and building high-performing organizations. He brings a practical perspective on leadership, authenticity, and the responsibility leaders have to help their teams grow. Key Takeaways Authenticity alone isn't enough. Being your authentic self does not automatically make you an effective or admirable leader. Leadership is about serving others. Great leaders focus on helping their people succeed, not simply on their own performance. Trust starts with authenticity. Teams are more likely to connect with leaders who are genuine and consistent in how they show up. Leadership requires self-awareness. Understanding your strengths, weaknesses, and impact on others is essential to becoming a better leader. People matter. The strongest leadership approach puts the development and success of the team at the center. Connect with Ken LinkedIn: https://www.linkedin.com/in/kensher/ (https://www.linkedin.com/in/kensher/) Website: https://shercoaching.com/ (https://shercoaching.com/) Connect with Keith Willis & Inside Pharma Leadership Instagram: https://www.instagram.com/coachtoachieve/ (https://www.instagram.com/coachtoachieve/) LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

4. 

   24 Aug 2026

   Ep15 - AI in Pharma: From Tool to Teammate with Darshan Kulkarni

   AI is changing how pharma professionals learn, work, and make decisions. In this episode, I sit down with Darshan Kulkarni to explore what it means to train with AI rather than simply train on AI, and how professionals can use these tools to become more effective. Meet the Guest Darshan Kulkarni is a lawyer, pharmacist, educator, and life sciences professional who brings a unique perspective to the intersection of law, healthcare, compliance, and AI. He teaches at Drexel University’s Thomas Kline School of Law and has extensive experience working across the pharmaceutical and healthcare industries. In this conversation, Darshan shares his perspective on how AI is changing the way professionals learn and work, why we should think about training with AI rather than simply training on AI, and how legal, ethical, and human considerations need to remain part of the conversation as AI continues to evolve. Key Takeaways Why we need to shift from training on AI to training with AI How AI can become a partner in learning and decision-making Why AI literacy matters for pharma professionals The importance of human judgment and critical thinking when using AI How educators and leaders can prepare teams for an AI-enabled future Why the biggest opportunity may be learning how to work alongside AI, not simply learning how AI works Connect With Darshan Kulkarni LinkedIn: https://www.linkedin.com/in/darshankulkarni/ (https://www.linkedin.com/in/darshankulkarni/) Website: www.kulkarnilawfirm.com (http://www.kulkarnilawfirm.com) Connect with Keith Willis & Inside Pharma Leadership Instagram: https://www.instagram.com/coachtoachieve/ (https://www.instagram.com/coachtoachieve/) LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

5. 

   7 Aug 2026

   Ep14 - AI Is Expanding the Role of the Salesperson with Keith Dodson

   In this episode of Inside Pharma Leadership, I sit down with Keith Dodson to explore how AI is reshaping sales, expanding what sales professionals can accomplish, and changing the skills leaders need to develop for the future. Meet the Guest Keith Dodson brings deep experience in sales and leadership, with a focus on how technology and AI can help sales professionals become more effective while expanding their capabilities. Key Takeaways AI can expand a salesperson’s territory and functional capabilities. The future of sales is about amplifying people, not simply replacing them. Sales professionals may be able to support more products, customers, and markets with AI. Leaders need to prepare their teams for how roles and expectations are changing. Human judgment, relationships, and leadership remain critical as AI becomes more integrated into sales. Connect with Keith Dodson LinkedIn: https://www.linkedin.com/in/keithdodson/ (https://www.linkedin.com/in/keithdodson/) Company/Website: http://insta-pill.com (http://insta-pill.com) Connect with Keith Dodson & Inside Pharma Leadership Instagram: @coachtoachieve LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

6. 

   29 Jul 2026

   Ep13 - How AI Is Transforming Early Disease Detection & the Future of Diagnostics with Shahid Rashid

   In this episode of Inside Pharma Leadership, I sit down with Shahid Rashid, Head of Product at Oncoustics, to explore how AI is transforming diagnostics and helping clinicians detect disease earlier. We discuss the journey from startup innovation to commercialization, the realities of bringing AI-enabled medical devices to market, and why customer-centered product development is essential for scaling healthcare innovation. Meet the Guest Shahid Rashid is the Head of Product at Oncoustics with more than 20 years of experience in engineering, healthcare technology, product strategy, and business development. After contributing to the NIH RADx initiative during COVID-19, Shahid now leads the development of AI-powered diagnostic solutions designed to improve early disease detection and expand access to quality healthcare worldwide. Key Takeaways How AI is making affordable diagnostic devices perform like high-end medical equipment. Why the best AI is often "invisible" to clinicians by fitting seamlessly into existing workflows. The challenges of scaling a healthcare startup from R&D to commercialization. Why customer feedback should guide every stage of product development. The importance of balancing innovation with safety, regulatory compliance, and cross-functional collaboration. Lessons for startup founders on raising capital, building the right team, and staying focused on customer needs. Why ethical, transparent, and scalable AI is critical for the future of healthcare. Connect with Shahid Rashid Connect with Shahid Rashid on LinkedIn: https://www.linkedin.com/in/shahidrashidsf/ (https://www.linkedin.com/in/shahidrashidsf/) Learn more about Oncoustics: www.oncoustics.com (http://www.oncoustics.com) Connect with Keith Willis & Inside Pharma Leadership Instagram: @coachtoachieve LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/video (https://www.youtube.com/@coremanagementtraining86/videos)

7. 

   2 Jul 2026

   Ep12 - The Future of Pharma Learning: AI Agents, Trust & Human Judgment (Part 2) with Parth Khanna

   What does it take to successfully scale AI across life sciences—and why are so many AI initiatives falling short? In Part 2 of this conversation, I am joined once again by Parth Khanna, CEO and Co-Founder of ACTO, to explore how AI agents are transforming Learning & Development, commercial teams, and the future of work. Together, they discuss why trust, governance, and human judgment are the missing ingredients in enterprise AI adoption—and how L&D has an opportunity to become a strategic driver of AI success. Meet the Guest Parth Khanna is the CEO and Co-Founder of ACTO, an AI-powered Intelligent Field Excellence platform trusted by leading pharmaceutical and biotech organizations. Passionate about the future of work, Parth helps life sciences companies leverage AI, agentic systems, and learning innovation to empower frontline teams, improve performance, and ultimately enhance patient outcomes. Key Takeaways Why AI adoption is less about technology and more about trust. The difference between building AI workflows and empowering an AI-enabled workforce. How role-based AI agents improve compliance, knowledge retrieval, and field performance. Why Learning & Development is uniquely positioned to lead AI governance and agent certification. The importance of balancing AI capabilities with human judgment, empathy, and accountability. Practical strategies for building AI systems that people actually trust and use. Connect with Parth Khanna 🔗 LinkedIn: https://www.linkedin.com/in/parth-khanna/ (https://www.linkedin.com/in/parth-khanna/) 📞 Phone: 289-800-1600 Connect with Keith Willis & Inside Pharma Leadership Instagram: @coachtoachieve LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

8. 

   11 Jun 2026

   Ep11 - The Hidden Role of L&D in Shaping AI-Driven Future of Work with Parth Khanna

   AI is reshaping the future of work, but success depends on more than technology. In this episode of Inside Pharma Leadership, I sit down with Parth Khanna, CEO and Co-Founder of ACTO, to explore how AI, agents, and augmented intelligence are transforming learning & development, frontline leadership, and commercial excellence in life sciences. They discuss the evolving role of L&D, why frontline managers are at the center of AI adoption, and how organizations can move beyond experimentation to create real business impact. Meet the Guest Parth Khanna is the CEO and Co-Founder of ACTO, an AI-powered platform trusted by leading pharmaceutical and biotech organizations to improve field force effectiveness and accelerate therapy adoption. With over 50,000 field professionals using ACTO across many of the world's top life sciences companies, Parth is a recognized thought leader in AI, learning & development, and the future of work. Key Takeaways ✅ Why AI should be viewed as Augmented Intelligence, not Artificial Intelligence ✅ How L&D teams can move from tactical support functions to strategic business partners ✅ The difference between Generative AI, AI Assistants, Agents, and Agentic AI ✅ Why frontline managers will be the key drivers of successful AI adoption ✅ How context and empathy improve AI performance and user trust ✅ The role of confidence, coaching, and personalized learning in AI-powered development ✅ Why job descriptions may be the blueprint for identifying AI opportunities ✅ How organizations can balance human connection, strategy, and judgment with AI automation Connect with Parth Khanna 🔗 LinkedIn: https://www.linkedin.com/in/parth-khanna/ (https://www.linkedin.com/in/parth-khanna/) 📞 Phone: 289-800-1600 Connect with Keith Willis & Inside Pharma Leadership Instagram: @coachtoachieve LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713) Spotify: https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f (https://open.spotify.com/show/2FREHTkAhT3VdZDdFa3jCV?si=85102c378a05412f) Youtube: https://www.youtube.com/@coremanagementtraining86/videos (https://www.youtube.com/@coremanagementtraining86/videos)

9. 

   29 May 2026

   Ep10 - The Black Box of Drug Discovery with David White

   In Episode 10 of Inside Pharma Leadership, I sit down with David White to explore the journey from scientific discovery to real-world patient impact. From drug development and commercialization to venture capital and biotech innovation, this episode dives into the business and science behind bringing life-changing therapies to market. Meet the Guest David White is a biopharma executive with more than 20 years of experience in drug discovery, strategic partnerships, and platform development. As SVP of Drug Discovery at ProteinQure, David has helped bridge the gap between cutting-edge science and commercially viable therapies across biotech, pharma, and venture-backed organizations. Key Takeaways Value creation and resource management in biopharma Decision-making based on unmet medical needs and landscape analysis The black box of early drug discovery and its excitement Transition from early discovery to commercialization with Target Product Profiles Drug repurposing and repositioning strategies Remote work and technology in drug discovery Challenges of raising capital in biotech Building a strong scientific advisory board for investment Balancing scientific innovation with business strategy Time as a critical resource in drug development Chapters 00:00 Introduction to Biopharma Leadership 01:13 The Journey of a Biopharma Leader 02:22 Value Creation in Drug Development 04:05 The Shift in Drug Discovery Dynamics 06:16 The Excitement of Early Drug Development 08:34 Transitioning from Discovery to Commercialization 12:15 The Process of Drug Repurposing 17:54 Business Aspects of Drug Development 21:24 Challenges in Raising Capital 26:14 Navigating Capital and Time Constraints 27:59 Closing Thoughts on Drug Discovery Connect with David White LinkedIn: https://www.linkedin.com/in/david-white-pharmaceuticals-biopharmaceuticals/ (https://www.linkedin.com/in/david-white-pharmaceuticals-biopharmaceuticals/) Email: david@proteinqure.com (mailto:david@proteinqure.com) Connect with Keith Willis & Inside Pharma Leadership Instagram: @coachtoachieve LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) Apple Podcast: https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713 (https://podcasts.apple.com/us/podcast/inside-pharma-leadership/id1882373713)

10. 

    12 May 2026

    Ep9 - The Hidden Cause of Veteran Suicide: Why Community Is the Real Cure with Marshall Spring

    In this episode, I’m joined by Marshall Spring to discuss the realities behind veteran suicide, the impact of isolation after service, and why rebuilding purpose and community is critical to recovery. Marshall shares how the Combat Recovery Foundation is helping veterans reconnect through service, resilience training, mentorship, and community-driven missions. Meet the Guest Marshall Spring is a combat Marine Corps Explosive Detection Dog Handler, former police officer, and founder of the Combat Recovery Foundation. After losing his business partner, a fellow Marine, to suicide in 2019, Marshall dedicated his life to suicide prevention, resilience coaching, and helping veterans navigate life after service. Key Takeaways Isolation is one of the biggest drivers of veteran suicidality Community, belonging, and purpose are essential to recovery Veterans often struggle more with asking for help than offering help Service-based missions can help veterans reconnect and heal Peer mentorship and one-on-one coaching can bridge the gap before group support Families and friends should watch for changes in behavior, mood, and increased isolation Suicide rates among veterans may be significantly higher than officially reported Connect with Marshall Spring Website: (https://combatrecoveryfoundation.org?utm_source=chatgpt.com)combatrecoveryfoundation.org (http://combatrecoveryfoundation.org) YouTube: Combat Recovery Foundation Instagram: @combatrecoveryfoundation LinkedIn: https://www.linkedin.com/in/marshallspring/ (https://www.linkedin.com/in/marshallspring/) Connect with Keith Willis Instagram: @coachtoachieve LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com)

11. 

    1 May 2026

    Ep8 - From Compliance to Capability: Rethinking Quality Leadership with Chris Hayden

    In this episode, I’m joined by Christopher Hayden to explore how AI is reshaping quality and compliance in life sciences. From smarter SOPs to human-first tech adoption, they unpack what’s changing—and what still matters most. Meet the Guest Christopher Hayden is a Partner Manager at Scilife, where he works at the intersection of technology, quality, and compliance. With a background spanning science, tech (including Google), and regulated industries, Chris helps life sciences organizations adopt smarter, more intuitive quality systems. Key Takeaways AI isn’t replacing jobs—it’s reshaping how work gets done The real opportunity: automate repetition, not experience SOPs are evolving from static text to interactive, visual, and even AR-based tools Human-first adoption (communication, trust, culture) is critical for successful tech implementation Change management—not technology—is the biggest barrier to execution The future of quality lies in smarter, more intuitive systems that empower people, not replace them Connect with Christopher Hayden LinkedIn: https://www.linkedin.com/in/chrisliamhayden/ (https://www.linkedin.com/in/chrisliamhayden/) Email: christopher.hayden@scilife.io (mailto:christopher.hayden@scilife.io) Connect with Keith LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com)

12. 

    23 Apr 2026

    Ep7 - Magic at Your Fingertips: How Maria Uses AI and UX to Disrupt Digital Design with Maria DeBuen

    In this episode of Inside Pharma Leadership, I sit down with Maria De Buen, founder of BluePixel, a premier international UX/UI design and software development firm. Maria shares her journey from starting a business straight out of college to leading a 60-person remote team that works with global giants like Office Depot and Philip Morris. The conversation dives deep into the evolution of digital design, the critical role of user experience in healthcare, and how generative AI is democratizing software development. Meet the Guest Maria De Buen is the founder of BluePixel, a premier international UX/UI design and custom software development firm. Originally trained as an industrial designer, Maria pivoted into the technology sector after identifying a significant gap in the Mexican market for specialized boutique firms that prioritize user experience. Over the last decade, she has successfully transitioned from a solo freelancer to a business leader, scaling her company into the #1 ranked UX/UI firm in Mexico. An expert in systemizing creative growth and integrating generative AI into design workflows, Maria is widely recognized for her ability to bridge the gap between complex engineering and intuitive, human-centric design for global brands. Key Takeaways 1. The Freelancer vs. Entrepreneur Mindset Maria highlights the difficult transition from being a "do-it-all" freelancer to a business leader. Scaling required her to stop expecting employees to be clones of herself and instead focus on systemization, delegation, and specialized roles. 2. UX/UI: The "Brain" of Digital Products Maria explains that technology fails if it isn't intuitive. UX (User Experience): The research-heavy logic, information architecture, and psychological understanding of the user journey. UI (User Interface): The creative, visual layer that makes the product accessible. Healthcare Application: In life sciences, design isn't just about "looks"—it's about accessibility (e.g., font size and button placement for elderly patients) and reducing errors in high-stakes environments. 3. AI as a "Magic" Force Multiplier Rather than fearing AI as a job-killer, Maria views it as an operating system for the brain. Speed: Tasks that once took months (like market research or initial prototyping) can now be compressed into a single week. Democratization: Tools are allowing non-technical leaders to build "decent" functional apps, though professional firms are still needed for high-level security, scalability, and complex databases. Connect with Maria and BluePixel Stay updated on the latest in UX/UI and digital innovation: LinkedIn: (https://www.linkedin.com)Maria De Buen (https://www.linkedin.com/in/maria-de-buen/) Instagram: Maria De Buen (https://www.instagram.com/mariadebuen/?hl=en) Tiktok: Maria De Buen (https://www.tiktok.com/@mariadebuen) Website: BluePixel (https://www.bluepixel.mx) Connect with Keith LinkedIn: Keith Willis (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com)

13. 

    16 Apr 2026

    Ep6 - Overcoming Imposter Syndrome in Finance with Karthik Sriram

    Karthik Sriram joins me to share how biotech finance leaders balance science, strategy, and capital to drive innovation. From his journey into the industry to raising over $800M, we unpack what it really takes to fund and scale life sciences companies—and why emotional intelligence is just as critical as financial expertise. Meet the Guest Karthik Sriram is a biotech finance executive currently leading Financial Planning & Analysis at Parabilis Medicines. With a background in biomedical engineering and an MBA from Wharton, he brings a unique ability to translate complex science into business strategy. He has helped secure more than $800M in capital, supporting clinical development, extending cash runway, and positioning companies for growth and partnerships. Key Takeaways Career paths aren’t linear—unexpected experiences often shape long-term direction Emotional intelligence is critical in finance, especially when influencing decisions and budgets Strong relationships and trust are essential to doing the job effectively OPEX vs. CAPEX decisions are foundational in biotech and directly impact scalability Raising capital requires honesty, clarity, and deep knowledge of your numbers Understanding the science—even at a high level—builds credibility with investors AI is accelerating drug development, especially in chemistry and early modeling The future of finance teams in biotech may be smaller, more automated, and AI-driven Early-stage companies face real barriers in adopting tools due to cost structures Flexibility—not fully remote or fully in-office—is the most effective operating model Connect with Karthik LinkedIn: https://www.linkedin.com/in/karthiksriram (https://www.linkedin.com/in/karthiksriram)X (Twitter): https://x.com/KarthikSriram_ (https://x.com/KarthikSriram_) Email: ksriram@parabilismed.com (mailto:ksriram@parabilismed.com) Connect with Keith LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/) Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com)

14. 

    10 Apr 2026

    Ep5 - Why Most Companies Struggle (And How the Best Win) with Kevin Stealey

    Kevin Stealey joins me to break down what separates companies that consistently win from those that struggle—and why clarity and alignment are at the core of execution. We also dive into the importance of simplifying complexity in today’s data-heavy, fast-moving organizations. Meet the Guest Kevin Stealey is a seasoned executive with a track record of accelerating profitable growth across consumer packaged goods and life sciences. He’s the CEO of RTR Technovation Corporation and author of Winning Bets: Leadership Lessons from a Father’s Football Pool, where he shares practical leadership insights rooted in real-life experiences. Key Takeaways Clarity + alignment = execution. Without both, progress stalls. Simplicity is a competitive advantage—especially in complex industries like pharma. More data doesn’t equal better communication—focus on what truly matters. Great leaders empower teams with clear direction and defined guardrails. As organizations grow, misalignment increases—intentional communication becomes critical. The higher you go in leadership, the simpler communication needs to be. Connect with Kevin LinkedIn: https://www.linkedin.com/in/kevinstealey/ (https://www.linkedin.com/in/kevinstealey/) Instagram: @kevinstealey Connect with Keith LinkedIn: https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/)

15. 

    31 Mar 2026

    Ep4 - Part 2 of Unlocking the Secrets of Aging: The Telomere Breakthrough with Bill Andrews

    Unlocking the Secrets of Aging: The Telomere Breakthrough Why hasn't the "cure" for aging been found? According to molecular geneticist Bill Andrews, it’s not a lack of science—it’s a broken system. In this episode, the man who helped discover the "cellular ride tickets" (telomeres) that dictate our lifespan explains why the current biotech model favors profits over cures. We dive into the Hayflick Limit, the discovery of Telomerase, and the $130 million road map to making the "Betty White Test"—reversing 85 to 25—a biological reality. Meet the Guest: Bill Andrews, PhD Bill Andrews is the Founder and CEO of Sierra Sciences and a legendary molecular geneticist. With a career defined by "curing over publishing," Bill has been a key inventor for breakthrough therapies including Human Growth Hormone, Rytelo (cancer), and treatments for Multiple Sclerosis. He is one of the world’s leading experts on telomere biology and is famously obsessed with one goal: curing death by old age. Key Takeaways The "Ride Ticket" Theory: Our cells have a finite number of divisions (The Hayflick Limit). Every time a cell divides, the telomeres (caps on our chromosomes) shorten until the "tickets" run out. The Telomerase Secret: Our reproductive cells don't age because they produce telomerase, an enzyme that adds "tickets" back to the chromosomes. Bill’s mission is to trigger this in all human cells. The System is Broken: Academic research is trapped in a "publish or perish" cycle, while biotech is often throttled by investors seeking quick ROI rather than long-term cures. The $130M Milestone: Bill estimates that with $130 million and three years of focused research, we could effectively cure human aging. Proof in Pets: Breakthroughs are already happening in the veterinary world with products designed to extend the lifespan of dogs, cats, and horses. Connect With Us Enjoyed this deep dive into the future of medicine? Let’s keep the conversation going: Bill Andrews: https://www.linkedin.com/in/william-h-andrews-ceo-5455b45/ (https://www.linkedin.com/in/william-h-andrews-ceo-5455b45/) Keith Willis:https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/)

16. 

    27 Mar 2026

    Ep4 - Unlocking the Secrets of Aging: The Telomere Breakthrough with Bill Andrews

    Why hasn't the "cure" for aging been found? According to molecular geneticist Bill Andrews, it’s not a lack of science—it’s a broken system. In this episode, the man who helped discover the "cellular ride tickets" (telomeres) that dictate our lifespan explains why the current biotech model favors profits over cures. We dive into the Hayflick Limit, the discovery of Telomerase, and the $130 million road map to making the "Betty White Test"—reversing 85 to 25—a biological reality. Meet the Guest: Bill Andrews, PhD Bill Andrews is the Founder and CEO of Sierra Sciences and a legendary molecular geneticist. With a career defined by "curing over publishing," Bill has been a key inventor for breakthrough therapies including Human Growth Hormone, Rytelo (cancer), and treatments for Multiple Sclerosis. He is one of the world’s leading experts on telomere biology and is famously obsessed with one goal: curing death by old age. Key Takeaways The "Ride Ticket" Theory: Our cells have a finite number of divisions (The Hayflick Limit). Every time a cell divides, the telomeres (caps on our chromosomes) shorten until the "tickets" run out. The Telomerase Secret: Our reproductive cells don't age because they produce telomerase, an enzyme that adds "tickets" back to the chromosomes. Bill’s mission is to trigger this in all human cells. The System is Broken: Academic research is trapped in a "publish or perish" cycle, while biotech is often throttled by investors seeking quick ROI rather than long-term cures. The $130M Milestone: Bill estimates that with $130 million and three years of focused research, we could effectively cure human aging. Proof in Pets: Breakthroughs are already happening in the veterinary world with products designed to extend the lifespan of dogs, cats, and horses. Connect With Us Enjoyed this deep dive into the future of medicine? Let’s keep the conversation going: Bill Andrews: https://www.linkedin.com/in/william-h-andrews-ceo-5455b45/ (https://www.linkedin.com/in/william-h-andrews-ceo-5455b45/) Keith Willis:https://www.linkedin.com/in/keithawillis/ (https://www.linkedin.com/in/keithawillis/)

17. 

    19 Mar 2026

    Ep3 - From Burnout to Breakthrough: Redefining Medical Fitness with Dr. Tran

    In Episode 3 of Inside Pharma Leadership, I sit down with Dr. Angela Tran, CEO & Founder of MedFit Medical Weight Loss, to talk about physician burnout, redefining how medicine is practiced, and what it really takes to achieve long-term, sustainable health. Dr. Tran shares her journey from burnout in traditional healthcare to building a practice centered on “medical fitness”—helping patients not just lose weight, but transform their lifestyle, reduce medications, and take ownership of their health. We also explore GLP-1 medications, wearable health tech, AI in medicine, and why mindset and support systems are often more important than diet and exercise alone. Meet the Guest Dr. Angela Tran is a board-certified physician, entrepreneur, and the CEO & Founder of MedFit Medical Weight Loss, which she launched in 2012. After experiencing severe burnout in traditional primary care, Dr. Tran made the decision to redefine how she practiced medicine—focusing on prevention, lifestyle transformation, and long-term patient outcomes. She specializes in obesity medicine and medical weight loss, helping patients reduce or eliminate medications while improving overall health. Her work combines clinical expertise, personal experience, and a strong emphasis on behavior, mindset, and accountability. Key Takeaways 1. Physician Burnout Is Real—and Can Lead to Reinvention Dr. Tran openly shares her experience with burnout and how it pushed her to leave traditional healthcare and build a practice aligned with her values and purpose. 2. Weight Loss Is More Than Diet and Exercise Sustainable weight loss starts with mindset. Beliefs, habits, and support systems play a critical role in long-term success. 3. GLP-1 Medications Are Transformational—When Used Correctly GLP-1s are changing the landscape of obesity and chronic disease treatment, but outcomes depend heavily on proper guidance and experienced providers. 4. Data and Wearable Tech Empower Patients Tools like continuous glucose monitors and fitness trackers provide objective data that help patients take control of their health and make better decisions. 5. AI Enhances—Not Replaces—Healthcare AI can provide speed, objectivity, and better decision support, but it works best when combined with human expertise and patient relationships. 6. The Right Support System Is Everything Long-term success isn’t just about knowledge—it’s about having the right people around you, from providers to family and community support. Connect with Dr. Tran Instagram: @medfitdrtran Email: drtran@denverweightlossclinic.com (mailto:drtran@denverweightlossclinic.com) LinkedIn: https://www.linkedin.com/in/drtrangela/ (https://www.linkedin.com/in/drtrangela/) Connect with Keith Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) LinkedIn: (https://www.linkedin.com/)www.linkedin.com/in/keithawillis/ (http://www.linkedin.com/in/keithawillis/)

18. 

    11 Mar 2026

    Ep2 - AI as a Tool, Not a Replacement: Insights from Experts with Lorrinda Gray-Davis

    In Episode 2 of Inside Pharma Leadership, I sit down with Lorrinda Gray-Davis to talk about the intersection of patient experience, healthcare policy, and innovation. Lorrinda shares how her personal journey through end-stage liver disease reshaped her career and led her into transplant advocacy, policy leadership, and building practical tools that help patients navigate access to medications and long-term care. Our conversation explores what healthcare leaders often miss about patient access, the critical role of care partners, and how emerging technologies like AI can help simplify complex healthcare systems. Meet the Guest Lorrinda Gray-Davis is a transplant advocate, speaker, and policy leader focused on improving patient access to care and medication affordability. Before entering healthcare advocacy, she spent more than 20 years in construction leadership, managing large-scale projects and leading teams across complex environments. After being diagnosed with end-stage liver disease, her experience navigating the healthcare system inspired her to dedicate her work to helping patients better understand and access the care they need. Today she is actively involved in transplant advocacy and policy work through Transplant Recipients International Organization, while also developing tools designed to help patients navigate medication access and healthcare systems more effectively. Key Takeaways 1. Healthcare Navigation Is Harder Than It Should Be Many patients enter the healthcare system without clear guidance. Lorrinda compares it to going on a safari without a guide—patients are expected to navigate complex systems while dealing with serious health challenges. 2. Access to Medication Is Still a Major Challenge From step therapy policies to insurance barriers, patients often struggle to access the medications they need. Education around copay cards, grants, and assistance programs can significantly reduce out-of-pocket costs. 3. Care Partners Are Critical to Patient Outcomes Lorrinda emphasizes the importance of involving “care partners” in medical conversations. These individuals often play a key role in helping patients understand treatment options and advocate for their care. 4. Technology Can Help Simplify Patient Access Lorrinda built the Transplant Medication Navigator to help patients identify financial assistance, copay programs, and insurance options in one centralized place. 5. AI Is a Tool for Amplifying Human Thinking Rather than replacing jobs, AI can serve as a thinking partner—helping leaders, innovators, and advocates build better tools and systems when paired with critical thinking. Connect with Lorrinda Website: lorrindagraydavis.com (http://lorrindagraydavis.com) Transplant Medication Navigator: transplantmedicationnavigator.com (http://transplantmedicationnavigator.com) Organization: Transplant Recipients International Organization LinkedIn: www.linkedin.com/in/lorrinda-gray-davis/ (http://www.linkedin.com/in/lorrinda-gray-davis/) Connect with Keith Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) LinkedIn: www.linkedin.com/in/keithawillis/ (http://www.linkedin.com/in/keithawillis/)

19. 

    4 Mar 2026

    Ep1 - From Dentistry to Non-Opioid Pain Solutions: A Journey of Innovation with Steven Fox

    The opioid crisis is the worst healthcare disaster in American history, yet for millions suffering from chronic pain, the only options are addiction or agony. What does it take to build a "Holy Grail" solution when there is no playbook? Steven Fox, a "rare kind of builder," joins us to discuss the high-stakes world of life science innovation, the art of surrounding yourself with "survivors," and why he believes he’s finally found the key to ending the opioid epidemic. Brief Description In this episode, Keith Willis sits down with Steven Fox, Chairman and Founder of Akelos Incorporated. From his roots as a cosmetic dentist to becoming an Ernst & Young Entrepreneur of the Year, Steven shares his 40-year journey of turning big ideas into public ventures. The conversation dives deep into the "three-dimensional chess" of biotech leadership: navigating the NIH grant system, building a world-class team of Nobel laureates without using headhunters, and the relentless tenacity required to move a non-opioid pain treatment toward FDA approval. Whether you are an aspiring entrepreneur or a seasoned executive, Steven’s "guerrilla warfare" approach to leadership offers a masterclass in survival and execution. Meet the Guest: Steven Fox Steven Fox is the Chairman and Founder of Akelos Inc., a biopharmaceutical company dedicated to solving the opioid crisis through non-addictive chronic pain treatments. A dentist by trade and a lifelong entrepreneur, Steven has: Developed 68 patents and raised over $75 million in capital. Taken a technology from the ADA public and placed products in 42,000 stores across America. Been awarded the Ernst & Young Entrepreneur of the Year and the Medal of Freedom from members of the U.S. Senate. Assembled a powerhouse team featuring former heads of neuroscience from Merck, Pfizer, and Eli Lilly, alongside Nobel Prize winners. Key Takeaways The "Survival" Team: Why "jockeys" are just as important as the "horse," and why Steven prefers team members seasoned in survival over S&P 500 pedigree. Bridging the Gap: How 48 years of treating dental pain provided the clinical insight needed to tackle the global opioid crisis. Entrepreneurial Tenacity: The reality of the 5 AM to 9 PM grind and why you have to be willing to "get up off the mat" repeatedly. The Patent Moat: The strategic (and sometimes costly) art of building intellectual property protection around groundbreaking science. Remaining "Sensationally Curious": Steven’s #1 piece of advice for anyone looking to innovate in a crowded marketplace. Connect with Steven Email: drstevefox@akelosinc.com (mailto:drstevefox@akelosinc.com) LinkedIn: (https://www.linkedin.com/)www.linkedin.com/in/drstevefox/ (http://www.linkedin.com/in/drstevefox/) Connect with Keith Email: kwillis@coremanagementtraining.com (mailto:kwillis@coremanagementtraining.com) LinkedIn: www.linkedin.com/in/keithawillis/ (http://www.linkedin.com/in/keithawillis/)

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

1 ratings

Contact Inside Pharma Leadership

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.